“Maladaptive stress-coping behavior in CX3CR1-deficient mice: Impact of adolescent stress and alcohol exposure on neuroimmune responses and inflammation”
The CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 chemokine axis regulates synaptic pruning, plasticity, and stress-related behaviors, influencing resilience or vulnerability to psychiatric disorders. Adolescence, a critical period for neuroimmune development, increases susceptibility to stressors. This study investigated how adolescent restraint stress and alcohol exposure affect stress-coping behavior, neuroimmune signaling, and systemic inflammation in adult wild-type (WT) and CX<sub>3</sub>CR1 knock-out (KO) mice. Eighty-one male and female WT and KO mice were assigned to control (non-stressed, saline-treated), stress (stressed, saline-treated), alcohol (non-stressed, alcohol-treated), and stress + alcohol (stressed, alcohol-treated) groups. Behavioral responses were evaluated using the tail suspension test. Hypothalamic gene expression of CX<sub>3</sub>CL1/CX<sub>3</sub>CR1, corticotropin-releasing hormone (CRH), and neuropeptide Y (NPY) systems was analyzed alongside plasma corticosterone, adrenocorticotropic hormone (ACTH), CX<sub>3</sub>CL1, and inflammatory mediators. Adolescent stress-but not alcohol-increased plasma CX<sub>3</sub>CL1 levels, which inversely correlated with immobility time in WT mice. KO mice displayed higher baseline immobility than WT mice, whereas stress and/or alcohol paradoxically reduced immobility. These behavioral effects were reproduced by pharmacological inhibition of CX<sub>3</sub>CR1. Additionally, KO mice showed disrupted hypothalamic expression of multiple genes in the CRH pathway and Npy1r, attenuated corticosterone responses to stress, and abolished ACTH-corticosterone correlation, suggesting HPA axis dysregulation. KO mice also exhibited exacerbated inflammatory responses to stress and alcohol, including elevated IL-17A/F, IL-11, and IFN-β1 levels. CX<sub>3</sub>CR1 deficiency disrupts neuroimmune homeostasis, leading to maladaptive stress-coping behaviors and heightened inflammatory reactivity. These findings underscore the protective role of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis in neuroinflammatory regulation and stress resilience, supporting CX<sub>3</sub>CR1 as a potential therapeutic target in stress-related disorders.
Authors
- Laura Sánchez‐Marín (ORCID: https://orcid.org/0000-0002-1160-4964)
- Antonia Serrano (ORCID: https://orcid.org/0000-0002-8017-9754)
- Fernando Rodrı́guez de Fonseca (ORCID: https://orcid.org/0000-0002-4516-5795)
- Maria J. Sanchez‐Quintero (ORCID: https://orcid.org/0000-0002-5638-2920)
- Laura Martín-Chaves
- Dina Medina‐Vera (ORCID: https://orcid.org/0000-0002-0342-1287)
- Ana Gavito (ORCID: https://orcid.org/0000-0002-2782-5999)
- Francisco Javier Pavón (ORCID: https://orcid.org/0000-0002-5256-8904)
- Manuel F. Jiménez‐Navarro (ORCID: https://orcid.org/0000-0002-6759-0514)
- Jorge Rodríguez‐Capitán (ORCID: https://orcid.org/0000-0001-6650-6264)
- O. V. Popova (ORCID: https://orcid.org/0009-0002-3749-588X)
- María Díaz-Ottaviano
Institutions
- Hospital Regional Universitario de Málaga (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Neuropharmacology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.neuropharm.2025.110503
- Citations
- 3
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.53